BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  Grünenthal Agrees US$ 922 m Deal With AstraZeneca for Nexium and Vimovo

  Biggest single investment in Grünenthal’s history that will significantly strengthen the company’s leading position in pain management

  October 30, 2018

   · 

  5 min read
• Job Trends

  Positive Preclinical Findings from Inhaled NanoPac® Lung Study Published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery

  Preclinical Study Demonstrated Inhaled NanoPac Shows Prolonged Retention and Limited Systemic Exposure

  October 30, 2018

   · 

  3 min read
• Business

  BioScience Managers appoints Dr. Kate Rowley as UK-based Investment Director

  BioScience Managers Limited today announces the appointment of Dr. Kate Rowley as Investment Director, based in London.

  October 30, 2018

   · 

  3 min read
• Business

  Schrödinger and WuXi AppTec Announce the Launch of Faxian Therapeutics to Enable Accelerated Drug Discovery

  The new venture will leverage the precision molecular design platforms developed by Schrödinger and accelerate them through partnership with the world-class lead optimization services provided by WuXi AppTec.

  October 30, 2018

   · 

  3 min read